A Phase 1 study of TAS-116 (pimitespib) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (NCT05245968)
TAIHO 10058060
This trial is No longer recruiting
Registration number NCT05245968
Program & service
This trial is being run with the Cancer service, and as part of the Medical Oncology program.
Trial phase
Phase 1
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor John Zalcberg
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR